QSAR Study of Potent Gsk-3β Inhibitor for Type II Diabetes
Chemometric analysis based methods for new therapeutic application
978-3-330-04043-4
3330040432
64
2017-02-20
35.90 €
eng
https://images.our-assets.com/cover/230x230/9783330040434.jpg
https://images.our-assets.com/fullcover/230x230/9783330040434.jpg
https://images.our-assets.com/cover/2000x/9783330040434.jpg
https://images.our-assets.com/fullcover/2000x/9783330040434.jpg
This is a best book for analyzing 2D QSAR technique for determining the potent GSK-3beta inhibitor against diabetes.Computer-aided drug design is a branch of medicinal/computational chemistry and is of great interest now a day. Computer-aided design of chemical compounds with controlled properties is generally performed using computer-aided design systems.Its becoming increasingly involved in understanding the differences between potent molecules and drug candidates (ADMET-absorption, distribution, metabolism, excretion and toxicity) this is already fueling a rise in impact and expectations for CADD. The use of quantitative structure-activity relationships (QSAR) has become increasingly helpful in understanding many aspects of chemical-biological interactions in drug and other scientific research. In the present effort, we exaggerate our pursuit of being establishing the relationship between the various physiochemical parameters and anti-diabetic activity of 3-aryl- 4-(arylhydrazono)-1H pyrazol-5-ones derivatives by using classical quantitative structure– activity relationship (QSAR) descriptors and similarity indices.
https://morebooks.de/books/fr/published_by/lap-lambert-academic-publishing/47/products
Pharmacie
https://morebooks.de/store/fr/book/qsar-study-of-potent-gsk-3%CE%B2-inhibitor-for-type-ii-diabetes/isbn/978-3-330-04043-4